TD Private Client Wealth LLC Acquires 12,105 Shares of CME Group Inc. $CME

TD Private Client Wealth LLC lifted its holdings in shares of CME Group Inc. (NASDAQ:CME) by 132.7% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 21,228 shares of the financial services provider’s stock after acquiring an additional 12,105 shares during the quarter. TD Private Client Wealth LLC’s holdings in CME Group were worth $5,797,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Asset Dedication LLC raised its holdings in shares of CME Group by 64.9% during the fourth quarter. Asset Dedication LLC now owns 94 shares of the financial services provider’s stock valued at $26,000 after acquiring an additional 37 shares in the last quarter. FNY Investment Advisers LLC bought a new position in shares of CME Group during the fourth quarter valued at approximately $27,000. Global Wealth Strategies & Associates raised its holdings in shares of CME Group by 1,250.0% during the fourth quarter. Global Wealth Strategies & Associates now owns 108 shares of the financial services provider’s stock valued at $30,000 after acquiring an additional 100 shares in the last quarter. Legacy Wealth Managment LLC ID raised its holdings in shares of CME Group by 191.9% during the fourth quarter. Legacy Wealth Managment LLC ID now owns 108 shares of the financial services provider’s stock valued at $29,000 after acquiring an additional 71 shares in the last quarter. Finally, Anfield Capital Management LLC raised its holdings in shares of CME Group by 197.4% during the fourth quarter. Anfield Capital Management LLC now owns 113 shares of the financial services provider’s stock valued at $31,000 after acquiring an additional 75 shares in the last quarter. Institutional investors own 87.75% of the company’s stock.

Insider Activity

In other news, Director Bryan T. Durkin sold 4,200 shares of the firm’s stock in a transaction on Monday, February 23rd. The stock was sold at an average price of $309.65, for a total transaction of $1,300,530.00. Following the completion of the transaction, the director directly owned 43,007 shares in the company, valued at $13,317,117.55. This trade represents a 8.90% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, General Counsel Jonathan L. Marcus sold 3,291 shares of the firm’s stock in a transaction on Tuesday, March 17th. The shares were sold at an average price of $333.37, for a total value of $1,097,120.67. Following the transaction, the general counsel owned 7,192 shares of the company’s stock, valued at $2,397,597.04. The trade was a 31.39% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 7,791 shares of company stock worth $2,489,421 over the last three months. 0.30% of the stock is currently owned by corporate insiders.

CME Group Price Performance

CME opened at $298.86 on Monday. The stock has a fifty day simple moving average of $298.07 and a two-hundred day simple moving average of $288.18. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.13. The company has a market cap of $108.29 billion, a price-to-earnings ratio of 25.50, a price-to-earnings-growth ratio of 3.61 and a beta of 0.23. CME Group Inc. has a 12-month low of $257.17 and a 12-month high of $329.16.

CME Group (NASDAQ:CME) last posted its quarterly earnings data on Wednesday, April 22nd. The financial services provider reported $3.36 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.11 by $0.25. The business had revenue of $1.88 billion during the quarter, compared to the consensus estimate of $1.77 billion. CME Group had a return on equity of 15.42% and a net margin of 63.19%.The firm’s quarterly revenue was up 14.5% compared to the same quarter last year. During the same quarter in the prior year, the company earned $2.80 earnings per share. Research analysts predict that CME Group Inc. will post 12.26 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, June 25th. Stockholders of record on Tuesday, June 9th will be issued a dividend of $1.30 per share. The ex-dividend date is Tuesday, June 9th. This represents a $5.20 annualized dividend and a dividend yield of 1.7%. CME Group’s dividend payout ratio (DPR) is presently 44.37%.

CME Group News Summary

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: CME Group announced plans to launch Nasdaq CME Crypto Index futures on June 8, pending regulatory review. The new contract would be CME’s first-ever market-cap weighted futures product and expands its regulated crypto offerings, which investors may view as a growth driver. Article: CME Group to Launch Nasdaq CME Crypto Index Futures
• Positive Sentiment: Reports that Interactive Brokers is integrating CME event contracts into a unified prediction-markets platform highlight CME’s growing relevance in new trading products and could support longer-term volume opportunities. Article: Interactive Brokers Debuts All-in-One Prediction Market Portal
• Positive Sentiment: Coverage of CME’s annual meeting preliminary results was routine governance news, but it showed no apparent disruption to the company’s leadership or shareholder base. Article: CME Group Inc. Announces Preliminary Results of 2026 Annual Meeting
• Neutral Sentiment: Multiple reports said CME and Intercontinental Exchange are lobbying U.S. regulators to increase scrutiny of Hyperliquid, arguing that the unregulated platform could affect price discovery in oil and crypto markets. This is more about competitive/regulatory positioning than a direct business event for CME, but it may be seen as CME defending the regulated futures ecosystem. Article: CME, ICE Push US to Curb Crypto’s Offshore Oil Trading Upstart
• Neutral Sentiment: Broader market commentary referenced CME’s FedWatch tool showing higher odds of a Fed hike later in 2026, but this is an indirect macro signal rather than company-specific news. Article: The Bond Market Just Fired A Warning Shot At The AI Rally — Fed Hike Ahead

Analyst Upgrades and Downgrades

A number of equities analysts recently commented on the company. Jefferies Financial Group decreased their target price on CME Group from $356.00 to $349.00 and set a “buy” rating for the company in a report on Thursday, April 9th. Barclays decreased their price objective on CME Group from $343.00 to $316.00 and set an “equal weight” rating for the company in a report on Thursday, April 23rd. Argus reiterated a “hold” rating on shares of CME Group in a report on Wednesday, March 4th. UBS Group reiterated a “neutral” rating and issued a $310.00 price objective on shares of CME Group in a report on Friday, February 6th. Finally, Weiss Ratings upgraded CME Group from a “buy (b+)” rating to a “buy (a-)” rating in a report on Monday, March 2nd. Two research analysts have rated the stock with a Strong Buy rating, eight have given a Buy rating, six have assigned a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat.com, CME Group presently has an average rating of “Moderate Buy” and a consensus target price of $305.29.

About CME Group

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.